Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes von Doroshow, Deborah B, Sanmamed, Miguel F, Hastings, Katherine, Politi, Katerina, Rimm, David L, Chen, Lieping, Melero, Ignacio, Schalper, Kurt A, Herbst, Roy S

Volltext

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer von Corredor, Germán, Wang, Xiangxue, Zhou, Yu, Lu, Cheng, Fu, Pingfu, Syrigos, Konstantinos, Rimm, David L, Yang, Michael, Romero, Eduardo, Schalper, Kurt A, Velcheti, Vamsidhar, Madabhushi, Anant

Volltext

Objective measurement and clinical significance of TILs in non-small cell lung cancer von Schalper, Kurt A, Brown, Jason, Carvajal-Hausdorf, Daniel, McLaughlin, Joseph, Velcheti, Vamsidhar, Syrigos, Konstantinos N, Herbst, Roy S, Rimm, David L

Volltext

Interleukin-8 in cancer pathogenesis, treatment and follow-up von Alfaro, Carlos, Sanmamed, Miguel F., Rodríguez-Ruiz, María E., Teijeira, Álvaro, Oñate, Carmen, González, Álvaro, Ponz, Mariano, Schalper, Kurt A., Pérez-Gracia, José L., Melero, Ignacio

Volltext

Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg? von Datar, Ila, Schalper, Kurt A

Volltext

Oncolytic virus immunotherapy: future prospects for oncology von Raja, Junaid, Ludwig, Johannes M, Gettinger, Scott N, Schalper, Kurt A, Kim, Hyun S

Volltext

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis von Datar, Ila, Sanmamed, Miguel F, Wang, Jun, Henick, Brian S, Choi, Jungmin, Badri, Ti, Dong, Weilai, Mani, Nikita, Toki, Maria, Mejías, Luis D, Lozano, Maria D, Perez-Gracia, Jose Luis, Velcheti, Vamsidhar, Hellmann, Matthew D, Gainor, Justin F, McEachern, Kristen, Jenkins, David, Syrigos, Konstantinos, Politi, Katerina, Gettinger, Scott, Rimm, David L, Herbst, Roy S, Melero, Ignacio, Chen, Lieping, Schalper, Kurt A

Volltext

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer von Villarroel-Espindola, Franz, Yu, Xiaoqing, Datar, Ila, Mani, Nikita, Sanmamed, Miguel, Velcheti, Vamsidhar, Syrigos, Konstantinos, Toki, Maria, Zhao, Hongyu, Chen, Lieping, Herbst, Roy S, Schalper, Kurt A

Volltext

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer von Schalper, Kurt A, Carvajal-Hausdorf, Daniel, McLaughlin, Joseph, Altan, Mehmet, Velcheti, Vamsidhar, Gaule, Patricia, Sanmamed, Miguel F, Chen, Lieping, Herbst, Roy S, Rimm, David L

Volltext

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers von Pelekanou, Vasiliki, Villarroel-Espindola, Franz, Schalper, Kurt A, Pusztai, Lajos, Rimm, David L

Volltext

Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1) von Velcheti, Vamsidhar, Rimm, David L., Schalper, Kurt A.

Volltext

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations von Remon, Jordi, Passiglia, Francesco, Ahn, Myung-Ju, Barlesi, Fabrice, Forde, Patrick M., Garon, Edward B., Gettinger, Scott, Goldberg, Sarah B., Herbst, Roy S., Horn, Leora, Kubota, Kaoru, Lu, Shun, Mezquita, Laura, Paz-Ares, Luis, Popat, Sanjay, Schalper, Kurt A., Skoulidis, Ferdinandos, Reck, Martin, Adjei, Alex A., Scagliotti, Giorgio V.

Volltext

Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer von Rehman, Jamaal A, Han, Gang, Carvajal-Hausdorf, Daniel E, Wasserman, Brad E, Pelekanou, Vasiliki, Mani, Nikita L, McLaughlin, Joseph, Schalper, Kurt A, Rimm, David L

Volltext

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC) von Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N, Herbst, Roy S, Rimm, David L, Schalper, Kurt A

Volltext

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential? von Nixon, Andrew B., Schalper, Kurt A., Jacobs, Ira, Potluri, Shobha, Wang, I-Ming, Fleener, Catherine

Volltext

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer von Mani, Nikita L, Schalper, Kurt A, Hatzis, Christos, Saglam, Ozlen, Tavassoli, Fattaneh, Butler, Meghan, Chagpar, Anees B, Pusztai, Lajos, Rimm, David L

Volltext

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research von Schalper, Kurt A, Kaftan, Edward, Herbst, Roy S

Volltext

The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation von Taube, Janis M, Akturk, Guray, Angelo, Michael, Engle, Elizabeth L, Gnjatic, Sacha, Greenbaum, Shirley, Greenwald, Noah F, Hedvat, Cyrus V, Hollmann, Travis J, Juco, Jonathan, Parra, Edwin R, Rebelatto, Marlon C, Rimm, David L, Rodriguez-Canales, Jaime, Schalper, Kurt A, Stack, Edward C, Ferreira, Cláudia S, Korski, Konstanty, Lako, Ana, Rodig, Scott J, Schenck, Emanuel, Steele, Keith E, Surace, Michael J, Tetzlaff, Michael T, von Loga, Katharina, Wistuba, Ignacio I, Bifulco, Carlo B

Volltext

Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology von Bera, Kaustav, Schalper, Kurt A., Rimm, David L., Velcheti, Vamsidhar, Madabhushi, Anant

Volltext

Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic von Carvajal-Hausdorf, Daniel E, Schalper, Kurt A, Neumeister, Veronique M, Rimm, David L

Volltext